Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine taking prasugrel and Qinlongkusu as active ingredients for treating cerebral infarction

Inactive Publication Date: 2016-08-31
QINGDAO YUNTIAN BIOTECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, among the drugs for the treatment of cerebral infarction, there is no report on the combination or preparation of prasugrel and taraurantin for the treatment of cerebral infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine taking prasugrel and Qinlongkusu as active ingredients for treating cerebral infarction
  • Medicine taking prasugrel and Qinlongkusu as active ingredients for treating cerebral infarction
  • Medicine taking prasugrel and Qinlongkusu as active ingredients for treating cerebral infarction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The preparation of embodiment 1 compound tablet

[0028]

[0029] Preparation process: firstly mix prasugrel and lactose evenly, then add sodium carboxymethyl starch and microcrystalline cellulose in turn, mix evenly, add draconin and mix evenly, finally add micropowder silica gel, magnesium stearate, mix evenly, and press into tablets , that is.

Embodiment 2

[0030] The preparation of embodiment 2 compound tablet

[0031]

[0032] Preparation process: first mix prasugrel and lactose evenly, then add microcrystalline cellulose and mix evenly, finally add draconin and mix evenly, and use 5% PVP k30 75% ethanol solution is used as a binder to granulate, dried, granulated, added with sodium carboxymethyl starch and magnesium stearate, mixed evenly, and compressed into tablets to obtain.

Embodiment 3

[0033] The preparation of embodiment 3 compound tablet

[0034]

[0035]

[0036] Preparation process: first mix prasugrel and lactose evenly, then add microcrystalline cellulose and mix evenly, finally add draconin and mix evenly, and use 5% PVP k30 75% ethanol solution is used as a binder to granulate, dried, granulated, added with sodium carboxymethyl starch and magnesium stearate, mixed evenly, and compressed into tablets to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, and relates to a medicine taking prasugrel and Qinlongkusu as active ingredients for treating cerebral infarction and application thereof. To solve the situation that no ideal medicine for treating cerebral infarction exists in current clinical application, the medicine composition for preventing and treating cerebral infarction is provided, and prasugrel and Qinlongkusu serving as active ingredients of the medicine composition have a remarkable synergistic effect in treatment of cerebral infarction and cerebral ischemia. The medicine is safe to take, and has a good clinical application prospect.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a medicine for treating cerebral infarction with prasugrel and draconin as active components, and its application. Background technique [0002] Cerebral infarction refers to the disorder of blood supply to the brain caused by various reasons, leading to brain tissue ischemia, hypoxic necrosis, and corresponding neurological deficits. Cerebral infarction is the most common type of CVD, accounting for about 70% of all CVD. It has become one of the major diseases that seriously endanger human health. Its disability rate ranks first, and its mortality rate is behind myocardial infarction and cancer. Therefore, the treatment of acute cerebral infarction is particularly important and directly affects the prognosis. [0003] There are various treatment methods for cerebral infarction. At present, the main treatment methods or methods include thrombolytic therapy, neuroprotective agent therapy, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/4365A61P9/10A61P35/00A61P7/04A61P25/00
CPCA61K31/4365A61K31/7048A61K2300/00
Inventor 王传秀
Owner QINGDAO YUNTIAN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com